230 related articles for article (PubMed ID: 31858536)
1. Down-regulation of long noncoding RNA PGM5-AS1 correlates with tumor progression and predicts poor prognosis in clear cell renal cell carcinoma.
Qian M; Zheng JL; Kang N; Su YL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10685-10690. PubMed ID: 31858536
[TBL] [Abstract][Full Text] [Related]
2. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.
Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K
J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743
[TBL] [Abstract][Full Text] [Related]
6. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
8. The Downregulation of lncRNA
Shen Y; Qi L; Li Y; Zhang Y; Gao X; Zhu Y; Wang K
Cancer Biother Radiopharm; 2021 Mar; 36(2):220-229. PubMed ID: 32354224
[No Abstract] [Full Text] [Related]
9. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
10. Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma.
Flippot R; Mouawad R; Spano JP; Rouprêt M; Compérat E; Bitker MO; Parra J; Vaessen C; Allanic F; Manach Q; Tannir NM; Khayat D; Su X; Malouf GG
Sci Rep; 2017 Aug; 7(1):8540. PubMed ID: 28819235
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis.
Wang Y; Li Z; Li W; Zhou L; Jiang Y
Medicine (Baltimore); 2019 Oct; 98(40):e17276. PubMed ID: 31577719
[TBL] [Abstract][Full Text] [Related]
14. p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis.
Zhihua Z; Weiwei W; Lihua N; Jianying Z; Jiang G
IUBMB Life; 2019 Oct; 71(10):1492-1502. PubMed ID: 31185143
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
Zhou Y; Zhang Z; Wo M; Xu W
Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
[TBL] [Abstract][Full Text] [Related]
16. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
Zhu H; Yu J; Zhu H; Guo Y; Feng S
World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
19. A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways.
Gao H; Chen W; Pan G; Liu H; Qian J; Tang W; Wang W; Qian S
Aging (Albany NY); 2022 Sep; 15(24):15624-15639. PubMed ID: 36170021
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
